Recursion Pharmaceuticals
American pharmaceutical company using AI-driven drug discovery.
Last updated September 11, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Recursion Pharmaceuticals is an American pharmaceutical company. According to its official website, it was founded more than a decade ago on the idea of taking images of cells and using them to train artificial intelligence to understand biological space and reduce the failure rate of traditional drug discovery. The company describes its Recursion OS drug discovery and development platform as having yielded an advanced pipeline of potential first-in-class and best-in-class treatments for conditions with high unmet need, including aggressive cancers and rare diseases.
History
Recursion Pharmaceuticals is an American pharmaceutical company. Its official website states that Recursion was founded more than a decade ago on the idea of taking images of cells and using these images to train artificial intelligence to understand the vast unknown biological space—the cellular disruptions driving disease—to use AI-drug discovery to reduce the massive 90% failure rate of traditional drug discovery. The company describes its mission as decoding biology to radically improve lives.
Products and positioning
Pioneering AI-driven solutions in drug discovery; using data and AI to bring better medicines to patients, faster.
Recent events
Bayer and Recursion enter strategic collaboration on fibrotic diseases[4]
Reported:
Bayer and Recursion Pharmaceuticals entered a strategic collaboration to use Recursion's AI-guided drug discovery platform and Bayer's compound library and scientific expertise to discover and develop treatments for fibrotic diseases.
Sources4 sources
Cite this profile: Cite the canonical profile. /brand-wiki/recursion-pharmaceuticals · Editorial policy · How profiles are compiled